Supplementary Table TS2 from Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer
BackgroundColorectal cancer (CRC) is the fifth most common cancer with rising prevalence in Vietnam. However, there is no data about the mutational landscape and actionable alterations in the Vietname
North America Circulating Tumor DNA (ctDNA) comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to foreca
Additional file 2: Supplementary Table S1. Genes included in the cfDNA assay. Supplementary Table S2. Clinical characteristics of CRC patients in the disease negative and positive group. Supplementary
